Colgate-Palmolive (NYSE: CL) awards stock to Americas COO
Colgate-Palmolive (CL) granted COO Shane Grant 50,902 stock options at $87.02 per share, expiring in 2036, and 7,355 restricted stock units. This increases his direct holdings to 79,503 shares and 50,902 options. The awards vest over three years, with no Rule 10b5-1 trading plan reported.
How this was made
The 30-second read
Why it matters
The grant adds to insider holdings but does not change the company's capital structure today.
Market read
Routine insider compensation with limited trading relevance.
What to watch
Potential future dilution if options are exercised at higher share price.
Background
Colgate‑Palmolive filed a disclosure of equity awards to its Americas COO.
Ticker impact
COO Shane Grant was granted 50,902 stock options and 7,355 RSUs on Sep 16, 2026.
Minimal impact; market likely to view as routine compensation.
The grant is a standard insider compensation event with no cash transaction or dilution effect until exercised.
Market effects
None; compensation grant is company‑specific.
None; limited to Colgate‑Palmolive shareholders.
Low; no broader market effect.
Counterpoint
Even routine grants can signal confidence in future performance.
Key entities
- ExecutiveShane Grant
COO, Americas


